14 research outputs found

    Integrated reaction-separation processes sequencing and screening at early stages of design

    Get PDF
    Process intensification and selection of the most efficient chemical process provides resources conservation and decreases the energy consumption to minimize CO2 emissions. Distillation Sequence Efficiency (DSE) method is extended to chemical processes also considering the reactors to provide a very simple and useful process design tool. A minimum amount of input data and computation power is required for a fast screening providing a basis for other more rigorous methods, i.e. including a cost assessment. The method considers, in a rough approach but at very early stages of process design, three factors related to environmental impact resources conservation and catalyst costs. The input data required is the vapour-liquid equilibrium represented by a proper thermodynamic model and some other predictable basic thermodynamic data. As it is an early stage approach, the reactor outputs can be assumed at chemical equilibrium minimizing the free Gibbs Energy. The ∞/∞ analysis is used to check the feasibility and calculate the stream flow rates and compositions. The distillation column output streams are at boiling point, and therefore the input data for the DSE method is available, which quantifies the process efficiency and therefore it is related to its environmental impact. A resources conservation factor, considering reactant losses, relates the product quantity generated to the amount that could be generated. A catalyst cost factor, considering catalyst deactivation, relates the feed raw materials to the system with the total feed stream to the reactor. ETBE (Ethyl Tert-Butyl Ether) production process is used as a case study. According to the results, the best alternative is the intensified process, i.e. reactive distillation, followed by the process proposed in the BREF. Other five alternative process schemes values are all in agreement with Recker et al. (2015) cost assessment results. However, there is disagreement between methods only in one case due to catalyst cost

    Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Get PDF

    Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

    Get PDF
    Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≄ II, EF ≀35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure < 100 mmHg (n = 1127), estimated glomerular filtration rate < 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation

    Investigating best available technique for CO2 chemical absorption: solvent selection based on empirical surrogate model and exergy loss

    Get PDF
    The carbon dioxide concentration in the atmosphere has reached extremely high levels, generating environmental concerns. Unfortunately, despite the climate change, CO2 is not included nowadays as a key environmental issue in Best Available Technique (BAT) reference documents (BREF). Industrially, the widespread industrial technology to capture CO2 is the chemical absorption using aqueous monoethanolamine (MEA) at 30%wt, which is the basis of comparison for novel alternative techniques in the literature and seems a suitable candidate to be proposed as Best Available Technique. Nevertheless, there is an intense research to find alternative solvents that decrease the energy consumption for carbon capture and many solvents are claimed in the literature to outperform MEA. A novel empirical surrogate model and exergy balances are used to confirm that MEA is still the best candidate to be proposed as Best Available Technique. The surrogate model proposed in this study properly regresses the CO2 gas liquid equilibrium data. The regressed parameters of the model are tabulated in this study for many aqueous alkanolamines and their mixtures, being the basis for computationally inexpensive chemical absorption column design. The surrogate model parameter considering the temperature is related with the chemical absorption energy and the consumed energy for solvent recovery. The obtained results show that none of the considered alkanolamine outperforms MEA in all the considered aspects, i.e. energy and solvent flowrate. MEA minimum flowrate is 15.62 mol solvent/mol gas and its heat of absorption regression parameter is − 27,745 J/mol. The proposed mathematical method is useful as a fast assessment for other novel alternatives that will be proposed in the future, providing energetically more efficient and cleaner technologies for CO2 capture

    Bioethanol dehydration and mixing by heterogeneous azeotropic distillation

    No full text
    Bioethanol is mixed with gasoline according to many countries' legislation pursuing environmental sustainability by reducing the use of fossil fuels. Bioethanol is produced by fermentation of many organic waste or biomass resources in diluted aqueous media. Unfortunately, bioethanol for fuel use must have a low content of water and its recovery is an energy intensive operation. Heterogeneous azeotropic distillation (HAD) is a well-known suitable option for dehydration of alcohols, e.g. ethanol. Many entrainers for this process are studied in literature and, in this study, is checked and verified that gasoline and gasoline additives present the lowest energy consumption. For this purpose, novel processes are proposed and rigorously simulated using AspenPlusÂź to verify their performance with respect to conventional processes used currently. Based on the simulation results, the processes are then compared in terms of environmental impact (expressed by the Potential Environmental Impact (PEI) index) and economic cost. Ethanol dehydration is a non-spontaneous process that requires energy to be accomplished and, on the other hand, mixing ethanol with gasoline and additives is a spontaneous process. Combining both processes in synergy in a single unit, energy consumption decreases by 50% and Potential Environmental Impact by 80%. Finally, the economic study indicated the benefits of employing the novel proposed scheme of one distillation column as CAPEX is reduced by 20% and the payback time to 1.5 years. Therefore, a novel viable process is proposed that greatly reduces the environmental impact of nowadays gasoline production
    corecore